Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MRK vs GSK✓SelectedUSD · GSKMRK vs GSK performance historyLatest closeAs of-2.23%11/16
Stock and ETF performance explorer

MRK vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+3,681.4%
GSK return
+1,741.1%
Excess return
+1,940.3%
Maximum drawdown
-68.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-2.2%-0.1%-2.2%-2.2%
7D-2.9%-1.3%-1.6%-2.3%
30D-1.0%+2.7%-3.8%-2.3%
3M+7.0%+2.7%+4.3%+5.7%
6M+31.4%+3.3%+28.1%+29.5%
YTD+40.1%+6.5%+33.6%+35.7%
1Y+60.0%+10.7%+49.4%+52.4%
3Y+55.2%+64.4%-9.1%+21.4%
5Y+100.1%+46.7%+53.4%+61.8%
10Y+228.0%+109.4%+118.7%+123.3%
All+3,681.4%+1,741.1%+1,940.3%+874.3%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling